View Clinical Trial (Medical Research Study)

Harnessing Placebo Effects: Non-Deceptive Use of Placebo in Irritable Bowel Syndrome (IBS) - NCT01010191-02115(Clinical Trial 400160)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Boston
State:  
MA
Zip Code: 02115
Conditions: Irritable Bowel Syndrome
Purpose: Irritable bowel syndrome patients will be given either placebo pill or no treatment for a period of 3 weeks.
Study summary: Seventy patients with irritable bowel syndrome (IBS) will be randomized to either 1) placebo pill or 2) no treatment and followed for 3 weeks. The study will involve three visits: baseline, midpoint and end point. At baseline all patients will physical examination, be evaluated for IBS and be administered standardized IBS questionnaires including: "IBS adequate relief" questionnaire, IBS global symptom improvement scale, IBS quality of life and IBS symptom severity scale. At midpoint and endpoint the same questionnaires will be administered. Patients on no treatment will be offered education on managing IBS at the end of the study.
Criteria: Inclusion Criteria: - Irritable bowel syndrome. Exclusion Criteria: - Any signs of organic bowel disease such as rectal bleeding. - No other major illnesses.
Study is available at: Beth Israel Deaconess Medical Center
Boston, MA 02115
United States

Primary Contact:
Anthony Lembo, MD
Email: alembo@bidmc.harvard.edu
Phone: 617-667-0682

Secondary Contact:
Anthony Lembo, MD
Email: alembo@bidmc.harvard.edu
Phone: 617.667.0682
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.